{"id":"NCT01979952","sponsor":"Boehringer Ingelheim","briefTitle":"Nintedanib Twice Daily vs Placebo in Patients Diagnosed With Idiopathic Pulmonary Fibrosis (IPF)","officialTitle":"A Six Month Double Blind Randomized Placebo Controlled Trial Followed by Each Arm Being Converted to Oral Nintedanib 150 mg Twice Daily Comparing the Effect on High Resolution Computerized Tomography Quantitative Lung Fibrosis Score, Lung Function, Six Minute Walk Test Distance and St. George's Respiratory Questionnaire After Six Months of Treatment in Patients With Idiopathic Pulmonary Fibrosis With Continued Evaluations Over a Period of up to Eighteen Months","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2013-11-26","primaryCompletion":"2016-10-27","completion":"2016-10-27","firstPosted":"2013-11-08","resultsPosted":"2018-04-17","lastUpdate":"2018-04-17"},"enrollment":113,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Idiopathic Pulmonary Fibrosis"],"interventions":[{"type":"DRUG","name":"Matching Placebo","otherNames":[]},{"type":"DRUG","name":"Nintedanib","otherNames":[]}],"arms":[{"label":"Nintedanib","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"This is an 6 month multi-centre, prospective, randomized, placebo controlled, double blind clinical trial followed by conversion of each arm to active nintedanib for an additional 6 months comparing the effect of nintedanib 150mg bis in die (BID twice daily) on the progression of IPF measured by using High Resolution Computerized Tomography(HRCT), lung function, functional component (6MWT), biomarkers, and PRO component (PROs) with continued treatment and assessments for up to 18 months.","primaryOutcome":{"measure":"Relative Change From Baseline in High Resolution Computerized Tomography (HRCT) Quantitative Lung Fibrosis (QLF) Score at 6 Months","timeFrame":"Baseline and 6 Months","effectByArm":[{"arm":"Nintedanib","deltaMin":11.407,"sd":4.4819},{"arm":"Placebo","deltaMin":14.583,"sd":4.3297}],"pValues":[{"comp":"OG000 vs OG001","p":null}]},"eligibility":{"minAge":"40 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":25,"countries":["United States","Canada","Turkey (TÃ¼rkiye)"]},"refs":{"pmids":["33902584"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":11,"n":56},"commonTop":["Diarrhoea","Nausea","Cough","Fatigue","Vomiting"]}}